Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Virtual Biopsy Global Market Report 2025
Download Free Sample Buy Now
Global Virtual Biopsy Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Virtual Biopsy Global Market Report 2025

By Target Thrapeutic Areas (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas), By Cancer Targeted (Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds), By Imaging Technologies (Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies), By End Users (Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Virtual Biopsy Market Overview

• Virtual Biopsy market size has reached to $0.63 billion in 2024

• Expected to grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%

• Growth Driver: Rising Prevalence Of Oncological Disorders Fueling The Growth Of The Market Due To Increasing Cancer Cases And Non-Invasive Diagnosis Methods

• Market Trend: AI-Driven Platform Enhances Non-Invasive Disease Detection With Advanced MRI Technology

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Virtual Biopsy Market?

Virtual biopsy is a non-invasive diagnostic technique that uses advanced imaging technologies combined with computer algorithms to analyze tissues for signs of disease. Its primary purpose is to detect abnormalities, such as tumors or infections, without the need for a traditional tissue sample, reducing risks and recovery time for patients. This method is safer, faster, and less painful than traditional biopsies.

The main target therapeutic areas of virtual biopsy include oncological disorders, neurological disorders, cardiovascular disorders, ophthalmological disorders, endocrine disorders, gastrointestinal disorders, and other related conditions. Oncological disorders encompass a group of diseases marked by the uncontrolled growth and spread of abnormal cells, commonly known as cancer, which can affect various organs and tissues. Virtual biopsy targets various cancers, such as solid malignancies, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The imaging technologies used in virtual biopsy include magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, and others, and are used for end users, including hospitals and clinics, research institutes, diagnostic centers, and others.

Virtual Biopsy Market Size and growth rate 2025 to 2029: Graph

What Is The Virtual Biopsy Market Size 2025 And Growth Rate?

The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing demand for non-invasive diagnostic methods, growing preference for early disease detection, rising efficiency in medical imaging software, increasing patient convenience and comfort, and rising availability of telemedicine services.

What Is The Virtual Biopsy Market Growth Forecast?

The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to a growing focus on cost-effective healthcare solutions, a growing focus on preventive healthcare measures, a growing demand for personalized medicine, a rising demand for minimally invasive cancer treatments, and the growing importance of precision oncology. Major trends in the forecast period include developing imaging sensors, developing multimodal biopsy techniques, integration with robotics for precision, innovation in non-invasive biomarker detection, and integration with three-dimensional (3D) visualization tools.

The forecast of 11.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for optical coherence tomography probes and AI-based image analysis software, sourced from key regions such as Israel and the Netherlands, could lead to reduced availability of non-invasive tissue assessment technologies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Virtual Biopsy Market Segmented?

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, aortic aneurysm, Valvular Heart Disease, myocardial infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

What Is Driving The Virtual Biopsy Market? Rising Prevalence Of Oncological Disorders Fueling The Growth Of The Market Due To Increasing Cancer Cases And Non-Invasive Diagnosis Methods

The rising prevalence of oncological disorders is expected to propel the growth of the virtual biopsy market going forward. Oncological disorders are health conditions related to cancer, where abnormal cells grow and spread in the body. The rising prevalence of oncological disorders is primarily due to lifestyle changes such as poor diet, physical inactivity, tobacco use, and increasing exposure to environmental pollutants. Virtual biopsy enhances the diagnosis and monitoring of oncological disorders by providing non-invasive, real-time imaging insights that reduce the need for traditional tissue biopsies while improving accuracy and patient safety. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia rose to 160,570 in 2022, marking an increase of 3,789 cases compared to 156,781 in 2021. Therefore, the rising prevalence of oncological disorders is driving the growth of the virtual biopsy industry.

Who Are The Major Players In The Global Virtual Biopsy Market?

Major companies operating in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc.

What Are The Key Trends Of The Global Virtual Biopsy Market? AI-Driven Platform Enhances Non-Invasive Disease Detection With Advanced MRI Technology

Major companies operating in the virtual biopsy market are focusing on developing technologically advanced solutions and getting approvals, such as the magnetic resonance spectroscopy (MRS) platform, to enhance non-invasive diagnostic accuracy and provide real-time analysis for early disease detection and personalized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that helps virtual biopsy by providing detailed molecular information of tissues, enabling accurate, real-time disease detection and monitoring without the need for invasive procedures. For instance, in November 2023, BrainSpec Inc., a US-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for the artificial intelligence (AI)-driven BrainSpec platform. This technology uses advanced artificial intelligence (AI) analysis of MR spectroscopy data to measure brain metabolites such as 2-hydroxyglutarate, facilitating non-invasive virtual biopsies for the diagnosis of conditions such as gliomas, alzheimer’s, and multiple sclerosis. The system integrates seamlessly with standard magnetic resonance imaging (MRI) scanners, automates data processing, and provides results within minutes. It also utilizes a reference database of brain chemistry to improve diagnostic accuracy.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Virtual Biopsy Market? Quibim Partners With Microsoft To Enhance Virtual Biopsy Tools Using AI And Azure Cloud

In July 2022, Quibim S.L., a Spain-based healthtech company, partnered with Microsoft Corporation to develop virtual biopsies with artificial intelligence. This partnership aims to enhance non-invasive diagnostics by combining Quibim’s AI imaging technology with Microsoft’s Azure cloud platform, improving accuracy in disease detection and reducing reliance on traditional biopsies. Microsoft Corporation is a US-based technology company that is widely known for developing, licensing, and supporting a wide range of software products and services.

What Is The Regional Outlook For The Global Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Virtual Biopsy Market?

The virtual biopsy market consists of revenues earned by entities by providing services such as imaging diagnostics, artificial intelligence (AI)-based interpretation, biomarker testing, telemedicine services, and three-dimensional (3D) tissue modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual biopsy market also includes sales of biopsy needle systems, artificial intelligence (AI)-based diagnostic tools, endoscopic systems, and photoacoustic imaging devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Virtual Biopsy Industry?

The virtual biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the virtual biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Virtual Biopsy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $0.71 billion
Revenue Forecast In 2034 $1.11 billion
Growth Rate CAGR of 11.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The virtual biopsy market covered in this report is segmented –
1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas
2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds
3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies
4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users Subsegments:
1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers
2) By Neurological Disorders: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions
3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions
4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders
5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions
6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions
7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Virtual Biopsy Market Characteristics

3. Virtual Biopsy Market Trends And Strategies

4. Virtual Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Virtual Biopsy Growth Analysis And Strategic Analysis Framework

5.1. Global Virtual Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Virtual Biopsy Market Growth Rate Analysis

5.4. Global Virtual Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Virtual Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Virtual Biopsy Total Addressable Market (TAM)

6. Virtual Biopsy Market Segmentation

6.1. Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncological Disorders

Neurological Disorders

Cardiovascular Disorders

Ophthalmological Disorders

Endocrine Disorders

Gastrointestinal Disorders

Other Target Therapeutic Areas

6.2. Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solid Malignancies

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Brain Cancer

Other Cancer Targeteds

6.3. Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Magnetic Resonance Imaging

Computed Tomography

X-Ray

Ultrasound

Other Imaging Technologies

6.4. Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Research Institutes And Diagnostic Centers

Other End Users

6.5. Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Cancer

Breast Cancer

Prostate Cancer

Colorectal Cancer

Liver Cancer

Brain Tumors

Other Cancers

6.6. Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Epilepsy

Brain Injuries

Stroke

Other Neurological Conditions

6.7. Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Coronary Artery Disease

Heart Failure

Arrhythmias

Aortic Aneurysm

Valvular Heart Disease

Myocardial Infarction

Other Cardiovascular Conditions

6.8. Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Age-Related Macular Degeneration

Diabetic Retinopathy

Glaucoma

Retinal Vein Occlusion

Cataracts

Other Eye Disorders

6.9. Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diabetes Mellitus

Thyroid Disorders

Adrenal Gland Disorders

Pituitary Gland Disorders

Parathyroid Disorders

Other Endocrine Conditions

6.10. Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inflammatory Bowel Disease

Colorectal Polyps

Gastric Ulcers

Liver Cirrhosis

Pancreatic Disorders

Hepatitis

Other Gastrointestinal Conditions

6.11. Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Musculoskeletal Disorders

Renal Disorders

Pulmonary Disorders

Hematologic Disorders

Dermatological Disorders

Infectious Diseases

Other Miscellaneous Conditions

7. Virtual Biopsy Market Regional And Country Analysis

7.1. Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Virtual Biopsy Market

8.1. Asia-Pacific Virtual Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Virtual Biopsy Market

9.1. China Virtual Biopsy Market Overview

9.2. China Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Virtual Biopsy Market

10.1. India Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Virtual Biopsy Market

11.1. Japan Virtual Biopsy Market Overview

11.2. Japan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Virtual Biopsy Market

12.1. Australia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Virtual Biopsy Market

13.1. Indonesia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Virtual Biopsy Market

14.1. South Korea Virtual Biopsy Market Overview

14.2. South Korea Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Virtual Biopsy Market

15.1. Western Europe Virtual Biopsy Market Overview

15.2. Western Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Virtual Biopsy Market

16.1. UK Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Virtual Biopsy Market

17.1. Germany Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Virtual Biopsy Market

18.1. France Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Virtual Biopsy Market

19.1. Italy Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Virtual Biopsy Market

20.1. Spain Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Virtual Biopsy Market

21.1. Eastern Europe Virtual Biopsy Market Overview

21.2. Eastern Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Virtual Biopsy Market

22.1. Russia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Virtual Biopsy Market

23.1. North America Virtual Biopsy Market Overview

23.2. North America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Virtual Biopsy Market

24.1. USA Virtual Biopsy Market Overview

24.2. USA Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Virtual Biopsy Market

25.1. Canada Virtual Biopsy Market Overview

25.2. Canada Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Virtual Biopsy Market

26.1. South America Virtual Biopsy Market Overview

26.2. South America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Virtual Biopsy Market

27.1. Brazil Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Virtual Biopsy Market

28.1. Middle East Virtual Biopsy Market Overview

28.2. Middle East Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Virtual Biopsy Market

29.1. Africa Virtual Biopsy Market Overview

29.2. Africa Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Virtual Biopsy Market Competitive Landscape And Company Profiles

30.1. Virtual Biopsy Market Competitive Landscape

30.2. Virtual Biopsy Market Company Profiles

30.2.1. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Virtual Biopsy Market Other Major And Innovative Companies

31.1. Hologic Inc.

31.2. Illumina Inc.

31.3. Guardant Health Inc.

31.4. Esaote S.p.A

31.5. Samsung Medison Co Ltd.

31.6. Telix Pharmaceuticals Limited

31.7. Freenome Holdings Inc.

31.8. Perspectum Ltd.

31.9. QUIBIM S.L

31.10. IQ-AI Limited

31.11. BrainSpec Inc.

31.12. Company 17

31.13. Company 18

31.14. Company 19

31.15. Company 20

32. Global Virtual Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Virtual Biopsy Market

34. Recent Developments In The Virtual Biopsy Market

35. Virtual Biopsy Market High Potential Countries, Segments and Strategies

35.1 Virtual Biopsy Market In 2029 - Countries Offering Most New Opportunities

35.2 Virtual Biopsy Market In 2029 - Segments Offering Most New Opportunities

35.3 Virtual Biopsy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Canon Inc. Financial Performance
  • Table 83: Siemens Healthineers AG Financial Performance
  • Table 84: GE Healthcare Financial Performance
  • Table 85: Quest Diagnostics Incorporated Financial Performance
  • Table 86: Olympus Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Canon Inc. Financial Performance
  • Figure 83: Siemens Healthineers AG Financial Performance
  • Figure 84: GE Healthcare Financial Performance
  • Figure 85: Quest Diagnostics Incorporated Financial Performance
  • Figure 86: Olympus Corporation Financial Performance

Gait Analyzer Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Gait Analyzer Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Gynecology Surgical Forceps Market Projected to Reach $16.54 Billion by 2029 at a CAGR of 6.3%

Read More About Global Gynecology Surgical Forceps Market Projected to Reach $16.54 Billion by 2029 at a CAGR of 6.3%

$11.02 Billion Forecast for Healthcare Mobile Robots Market by 2029, Backed by Demand and Innovation

Read More About $11.02 Billion Forecast for Healthcare Mobile Robots Market by 2029, Backed by Demand and Innovation

Heart Defect Closure Device Market Forecast Reaching $2.12 Billion by 2029 at 13.7% CAGR

Read More About Heart Defect Closure Device Market Forecast Reaching $2.12 Billion by 2029 at 13.7% CAGR

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Liquid Biopsy Global Market Report 2025 – By Product (Assays Kits, Instruments, Services), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics), By ...

View Report

Virtual Clinical Trials Global Market Report 2025 – By Design (Observational Trials, Interventional Trials, Expanded Access Trials), By Phases (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Infl...

View Report

Biopsy Devices Global Market Report 2025 – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, Stereotactic...

View Report

Biopsy Devices Global Market Report 2025 – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, Stereotactic...

View Report

Liquid Biopsy For Cancer Diagnostics Global Market Report 2025 – By Type (Product, Services), By Sample (Blood, Urine, Saliva), By Cancer (Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers), By End-User (Hospitals,...

View Report

Smart Biopsy Devices Global Market Report 2025 – By Product (Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Bio...

View Report

Virtual Colonoscopy Software Global Market Report 2025 – By Product Type (Two Dimensional (2D), Three Dimensional (3D)), By Deployment (On-Premises, Cloud-based), By Application (Polyps, Crohn's Disease, Ulcerative Colit...

View Report

Kidney Biopsy Global Market Report 2025 – By Type (Percutaneous Biopsy, Surgical Biopsy), By Indication (Kidney Failure, Kidney Transplant, Hematuria, Proteinuria), By End-User (Hospitals And Clinics, Urology Centers, Te...

View Report

Frequently Asked Questions

Virtual biopsy is a non-invasive diagnostic technique that uses advanced imaging technologies combined with computer algorithms to analyze tissues for signs of disease. Its primary purpose is to detect abnormalities, such as tumors or infections, without the need for a traditional tissue sample, reducing risks and recovery time for patients. This method is safer, faster, and less painful than traditional biopsies. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Oncological Disorders Fueling The Growth Of The Market Due To Increasing Cancer Cases And Non-Invasive Diagnosis Methods. For further insights on this market, request a sample here

The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing demand for non-invasive diagnostic methods, growing preference for early disease detection, rising efficiency in medical imaging software, increasing patient convenience and comfort, and rising availability of telemedicine services. The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to a growing focus on cost-effective healthcare solutions, a growing focus on preventive healthcare measures, a growing demand for personalized medicine, a rising demand for minimally invasive cancer treatments, and the growing importance of precision oncology. Major trends in the forecast period include developing imaging sensors, developing multimodal biopsy techniques, integration with robotics for precision, innovation in non-invasive biomarker detection, and integration with three-dimensional (3D) visualization tools. For further insights on this market, request a sample here

The virtual biopsymarket covered in this report is segmented –
1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas
2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds
3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies
4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users Subsegments:
1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers
2) By Neurological Disorders: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions
3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions
4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders
5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions
6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions
7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions For further insights on this market, request a sample here

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc. . For further insights on this market, request a sample here.

Major trends in this market include AI-Driven Platform Enhances Non-Invasive Disease Detection With Advanced MRI Technology. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Virtual Biopsy Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon